Timothy Lewis Cannon, Michael Rothe, Elizabeth Garrett-Mayer, Andrew Gregory, Meredith McKean, Kunal C. Kadakia, Evan P. Pisick, Bamidele Adesunloye, Jasdeepa Nagi, Erwin Grussie, Carmen Julia Calfa, Majd Chahin, Jaykumar Ranchodbhai Thumar, Stanley Madu Nwabudike, Gahyun Gim, Abigail Gregory, Dominique C. Hinshaw, Gina N. Grantham, Susan Halabi, Richard L. Schilsky. "Atezolizumab (A) plus pertuzumab/trastuzumab/hyaluronidase (PHESGO) in patients (pts) with solid tumors with ERBB2 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2644